Insights by Engage

Engage Health, a nationwide leader in reimbursement technologies and solutions, welcomes Steven A. Greenspan JD, LLM to the role of Chief Strategy Officer. In this role, Steven will leverage his in-depth knowledge of healthcare regulatory compliance and the resulting challenges faced by providers and payors alike, to lead the enterprise strategic growth initiatives at Engage, including product management and solution development.

One of the most discussed topics in the last month has been that of the recall by Philips Respironics. As you may know, on June 14th, 2021, Philips announced a voluntary, global recall of approximately 4 million continuous positive airway pressure (CPAP) devices, bilevel respiratory assist devices (BIPAP), and ventilators. The issue was, in essence, that Philips advised that there are potential health risks related to sound abatement foam used in specific Philips devices. The company has developed a comprehensive plan to replace the current sound abatement foam with a new material that is not affected by this issue and has already begun this process. This created quite the impact across the nation as suppliers were caught off-guard while  Philips worked through the specifics of the recall. In response, Philips made the following announcement on their website: